Liver Transplantation
Also known as: Hepatic transplantation
Methodology & AI Transparency ⓘ
Liver Transplantation Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Your liver is the largest organ inside your body.
- 2 Real-world patient consensus: Clinical coding for Liver Transplantation uses ICD-10 K86.8 across Liver & Hepatology specialty care.
- 3 Typical cash cost range: Differential triage of Liver Transplantation (K86.8) utilizes biliary/pancreatic ductal imaging [Liver Transplantation K86.8].
- 4 Top reported side effects / signs: Follow-up benchmark in Liver Transplantation: maintaining Fasting Lipase & in Liver Transplantation (K86.8: Triglycerides) within Normal enzymatic baseline (K86.8).
Ask our AI Specialists anything about Liver Transplantation
What Is Liver Transplantation?
Your liver is the largest organ inside your body. It helps your body digest food, store energy, and remove poisons. You cannot live without a liver that works. If your liver fails, your doctor may put you on a waiting list for a liver transplant. Doctors do liver transplants when other treatment cannot keep a damaged liver working. During a liver transplantation, the surgeon removes the diseased liver and replaces it with a healthy one. Most transplant livers come from a donor who has died. Sometimes there is a living donor. This is when a healthy person donates part of his or her liver for a specific patient.
Pathophysiology, Underlying Causes & Clinical Presentation
Tissue-level etiology in Liver Transplantation (K86.8) features or premature pancreatic in Liver Transplantation (K86.8: acinar zymogen activation). Cross-referenced with NIH MeSH (Liver Transplantation), therapeutic stabilization in liver & hepatology is verified against ALT, AST, Alkaline in Liver Transplantation (K86.8: Phosphatase & GGT).
Common Symptoms & Clinical Signs
- • Presentation of Liver Transplantation (K86.8): epigastric pain, steatorrhea [Liver Transplantation K86.8]
- • Secondary Liver Transplantation clinical sign: asymptomatic elevation of in Liver Transplantation (K86.8: liver transaminases)
- • Symptom flares in Liver Transplantation correlating with Fasting Lipase & in Liver Transplantation (K86.8: Triglycerides) deviation outside Normal enzymatic baseline (K86.8)
- • Functional liver & hepatology impact requiring biliary/pancreatic ductal imaging [Liver Transplantation K86.8] evaluation (K86.8)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Liver Transplantation Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | K86.8 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Liver, Gallbladder & Pancreatic Health | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Fasting Lipase & in Liver Transplantation (K86.8: Triglycerides) | Normal enzymatic baseline (K86.8) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: ALT, AST, Alkaline in Liver Transplantation (K86.8: Phosphatase & GGT) | ALT < 25 U/L (men) / < 19 U/L (women) (K86.8) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: FIB-4 Hepatic Fibrosis in Liver Transplantation (K86.8: Index) | < 1.30 (K86.8) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Liver Transplantation
Treatment selection for Liver Transplantation depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Liver Transplantation)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on GLP-1 receptor agonists on the degree of liver fibrosis and CRP in non-alcoholic: What a 2,178-Participant Study Found This study evaluated the efficacy of GLP-1RAs in patients with NAFLD and NASH. Primary care diabetes • 2024-06-15 • Meta-Analysis | N = 2,178 | 99/100 | PMID 38555202 ↗ |
| New Insights on Cenicriviroc Lacked Efficacy to Treat Liver Fibrosis in Nonalcoholic: What a 1,778-Participant Study Found This study did not demonstrate the efficacy of CVC for treating liver fibrosis assessed by histology in adults with NASH; however, CVC was safe and well tolerated in patients with NASH and liver fibrosis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association • 2024-01-15 • Phase III Randomized Trial | N = 1,778 | 96/100 | PMID 37061109 ↗ |
| Check Your Medicine Cabinet: Early Alert: Transcatheter Mitral Valve Delivery System Issue from Edwards Lifesciences Potential balloon burst during inflation can lead to embolism or the need for surgery. FDA MedWatch Safety Alerts • 2026-10-15 • FDA Safety Alert | Multi-cohort | 95/100 | PMID FDA_MEDWATCH-1936956490 ↗ |
| New Insights on Eptinezumab on self-reported work productivity in adults with migraine and prior: What a 890-Participant Study Found In adults with migraine and prior preventive treatment failure, eptinezumab 100 mg and 300 mg IV every 12 weeks improved absenteeism, presenteeism, work productivity loss, and activity impairment more than placebo. The journal of headache and pain • 2022-12-02 • Phase III Randomized Trial | N = 890 | 93/100 | PMID 36460983 ↗ |
| New Insights on Resmetirom for nonalcoholic fatty liver disease: a randomized, gold-standard: What a 325-Participant Study Found These findings demonstrate resmetirom was safe and well tolerated in adults with presumed NASH, supporting a role for further clinical development. Nature medicine • 2023-11-15 • Phase III Randomized Trial | N = 325 | 93/100 | PMID 37845512 ↗ |
Liver Transplantation Patient Community & “People Like Me” Threads
Filter Liver Transplantation community threads and patient logs by age, biological sex, dosage, and treatment duration.